Why Is Stablecoin Development Corp. (SDEV) Up 104% Today?
Healthcare's biggest mover today
Stablecoin Development Corp. is the biggest Healthcare gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
Latest updates
- October 7, 2026, 11:31 AM ET
There is fresh data on file. October 7th, 2026: SDEV qualified again, up +104.4%.
At a glanceMove today+104.4%Price$7.48Market cap$377.4 millionVolume vs average—52-week high$7.6552-week low$0.81Source: Market data · InsiderBuying.com - October 7, 2026, 11:00 AM ET
New disclosures have landed since the last refresh. October 7th, 2026: SDEV qualified again, up +104.4%.
- October 7, 2026, 10:26 AM ET
October 7th, 2026: SDEV qualified again, up +104.4%.
The move
SDEV trades at $7.48, up +104.4% on the session, with a market capitalisation of $377.4 million.
Volume for the session is not available, so the conviction behind the move cannot be judged from here.
Against its 52-week range of $0.81 to $7.65, today's price sits 98% of the way up it.
No company news on file
There is no company filing, analyst action or insider transaction on our record to explain today's move.
For context, Healthcare names are up an average of +1.1% today, so some of this is the sector rather than the company.
A move without a disclosed cause is common and not sinister. It is simply a move we cannot explain, and saying so is more useful than guessing.
| Metric | Value | Context |
|---|---|---|
| Change today | +104.4% | Healthcare average +1.1% |
| Volume | 145,207,943 | — |
| Market cap | $377.4 million | Medical - Pharmaceuticals |
| Range | $0.81 – $7.65 | 52 weeks |
| Metric | Value | Context |
|---|---|---|
| Change today | +104.4% | Healthcare average +1.1% |
| Volume | 145,207,943 | — |
| Market cap | $377.4 million | Medical - Pharmaceuticals |
| Range | $0.81 – $7.65 | 52 weeks |
The bottom line
A large move with no disclosed cause. That is worth knowing, and it is not a reason to act. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.
